NSE - Delayed Quote INR
Lincoln Pharmaceuticals Limited (LINCOLN.NS)
593.20
-6.55
(-1.09%)
At close: April 25 at 3:29:59 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
632,172
392,619
761,319
692,695
Investing Cash Flow
--
-573,416
-366,426
-780,802
-642,273
Financing Cash Flow
--
-51,804
-45,013
-25,561
-57,453
End Cash Position
--
57,472
50,520
69,340
114,383
Capital Expenditure
--
-396,130
-142,820
-455,252
-87,503
Issuance of Debt
--
200,000
193,574
20,000
--
Repayment of Debt
--
-209,019
-195,018
-5,197
-45,543
Free Cash Flow
--
236,042
249,799
306,067
605,192
3/31/2021 - 12/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SYSCHEM.BO Syschem (India) Limited
40.46
-2.76%
AUROLAB.BO Auro Laboratories Limited
242.50
-3.02%
SUVEN.BO Suven Life Sciences Limited
135.90
-3.48%
APLLTD.BO Alembic Pharmaceuticals Limited
875.45
-0.68%
GENNEX.BO Gennex Laboratories Limited
13.24
-4.20%
MOREPENLAB.BO Morepen Laboratories Limited
58.82
-5.43%
BLISSGVS.NS Bliss GVS Pharma Limited
121.87
-3.57%
STAR.NS Strides Pharma Science Limited
653.45
-4.05%
NEULANDLAB.BO Neuland Laboratories Limited
12,300.60
-5.99%
AJANTPHARM.NS Ajanta Pharma Limited
2,676.00
-4.10%